Impact of Escitalopram on Sperm DNA Fragmentation
common.study.values.description
“Impact of Escitalopram on Sperm DNA Fragmentation”
Double-blind placebo-controlled randomized trial of daily escitalopram for 6 weeks in healthy men with normal semen analyses and no psychiatric history of depression, bipolar, mania or suicidal ideation. Hormone profiles, semen analysis, sperm DNA fragmentation, and sexual function will be measured at baseline, after 6 weeks of therapy, and 4 weeks after discontinuation of therapy (10 weeks into study).
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Escitalopram
10mg by mouth daily for 6 weeks
Placebo
matched placebo control by mouth for 6 weeks
participant.views.study.view.additional
participant.views.study.view.scientific-title
Assessing the Impact of Escitalopram on Sperm DNA Fragmentation: A Randomized Placebo Controlled
common.study.values.clinical-trial-id
NCT03527043
participant.views.study.view.id
QbY4Aa
